Foundry Partners, LLC Gilead Sciences, Inc. Transaction History

Foundry Partners, LLC

$1.84 Billion
Q1 2024

A detailed history of Foundry Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Foundry Partners, LLC holds 200,778 shares of GILD stock, worth $13.8 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

200,778

Previous 194,423 3.27%

Holding current value

$13.8 Million

Previous $15.8 Million 6.63%

% of portfolio

0.8%

Previous 0.96%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $454,890 - $554,727	6,355 Added 3.27%	200,778 $14.7 Million
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $1.76 Million - $2 Million	-24,069 Reduced 11.02%	194,423 $15.8 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $98,266 - $107,210	-1,329 Reduced 0.6%	218,492 $16.4 Million
Q2 2023 Jul 12, 2023	SELL	$76.01 - $86.7 $6.87 Million - $7.83 Million	-90,340 Reduced 29.13%	219,821 $16.9 Million
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $2.42 Million - $2.75 Million	-31,258 Reduced 9.16%	310,161 $25.7 Million

Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $282,683 - $405,835	-4,536 Reduced 1.31%	341,419 $29.3 Million
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $20.6 Million - $23.5 Million	345,955 New	345,955 $21.3 Million
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $12.5 Million - $14.3 Million	-221,377 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$62.1 - $78.08 $3.47 Million - $4.37 Million	55,911 Added 33.79%	221,377 $14 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $993,662 - $1.15 Million	-13,736 Reduced 7.67%	165,466 $12.7 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $56,993 - $73,000	910 Added 0.51%	179,202 $13.4 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $6.58 Million - $7.24 Million	-106,767 Reduced 37.45%	178,292 $11.6 Million
Q3 2019 Oct 23, 2019	BUY	$62.51 - $69.0 $11.1 Million - $12.2 Million	176,990 Added 163.77%	285,059 $18.1 Million
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $6.69 Million - $7.5 Million	108,069 New	108,069 $7.3 Million
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $262,661 - $320,212	-3,606 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$71.15 - $83.52 $11.3 Million - $13.3 Million	-158,795 Reduced 97.78%	3,606 $258,000
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $11.7 Million - $13.9 Million	162,401	162,401 $13.2 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Account

Foundry Partners, LLC Gilead Sciences, Inc. Transaction History